InvestorsHub Logo
Followers 33
Posts 2924
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Tuesday, 08/06/2019 4:54:47 PM

Tuesday, August 06, 2019 4:54:47 PM

Post# of 300
A trial in Germany is testing a neoantigen based vaccine (+/- Bempeg) in pts with locally advanced or metastatic melanoma, NSCLC, RCC (clear), UC or squamous cell carcinoma of head and neck, who did not achieve a CR with current standard of care immune checkpoint blockade https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002474-39/DE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News